HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA tells kids to stop having Fun

This article was originally published in The Rose Sheet

Executive Summary

Fun Express is recalling six colors of children's face paint following "cluster" of adverse events reported to FDA. Agency says all exposures - which resulted in rashes, itchiness, burning and swelling - occurred on the same day at an organized event. An FDA laboratory has tested and confirmed "significant microbial contamination" in most of the products, according to May 12 release. Face paints were manufactured by Shanghai Color Art Stationery Company Limited in China and distributed by Oriental Trading Co. of Omaha, Neb., which owns Fun Express and whose name appears on product labeling. FDA's cosmetics office issued a notice in fall 2007 advising parents to compare ingredient lists on Halloween face paint and other novelty makeup items against agency's summary of approved color additives to avoid adverse skin reactions (1"The Rose Sheet" Oct. 29, 2007, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel